Hip Implants Market

The rise in the prevalence of arthritis is driving the market growth

The market CAGR for hip implants is anticipated to develop in the future due to the rise in the prevalence of arthritis. One or more joints become swollen and painful due to arthritis, which causes excruciating pain in the bones and joints. The two most prevalent kinds of arthritis are osteoarthritis and rheumatoid arthritis. Hip replacement surgeries, also known as hip arthroplasty, are frequently performed to relieve hip discomfort and restore hip function. During these procedures, artificial implants are utilized to replace any damaged or non-functioning elements of the hip joint.

For instance, the US-based national public health organization, the Centers for Disease Control and Prevention, estimates that in November 2021, 24% of all adults, or 58.5 million persons, will have arthritis.

It is the leading cause of work impairment, with yearly expenses for medical care and lost pay totaling $303.5 billion. In the US, individuals of working age make up the bulk of arthritis sufferers (around 57.3%). In addition, 20.3 million people in the UK experience musculoskeletal (MSK) problems like arthritis or back pain, according to a 2021 report by Versus Arthritis, a US-based nonprofit group dedicated to the disease. Therefore, the market for hip implants is expanding as arthritis is becoming more common.

For instance, the BMC Journal published an article about the RECOVER-E mobile app that is being developed to assist people who have had knee and hip surgery and are recovering.

The demand for hip implants is expected to increase as a result of adequate health insurance and changes to the health reimbursement laws for joint replacement surgeries. The governments of various nations have introduced a variety of health reimbursement programs for joint replacement surgery in an effort to provide everyone with access to inexpensive and high-quality healthcare. As a result, more people are having hip arthroplasty surgeries, which is boosting the market. Thus, driving the hip implants market revenue.

The Global Hip Implants Market Industry is projected to experience substantial growth over the coming years. By 2024, the market is anticipated to reach 10.2 USD Billion, with further growth expected to 14.9 USD Billion by 2035. This trajectory suggests a robust demand for hip implants driven by various factors, including demographic changes and advancements in medical technology. The compound annual growth rate (CAGR) of 3.54% from 2025 to 2035 indicates a steady expansion of the market, reflecting the increasing need for hip replacement surgeries and the ongoing development of innovative implant solutions.

Technological innovations in hip implant design and materials are transforming the Global Hip Implants Market Industry. The introduction of minimally invasive surgical techniques, coupled with advanced materials such as ceramics and titanium alloys, enhances the durability and performance of implants. These advancements not only improve patient outcomes but also reduce recovery times, making hip replacement surgeries more appealing. For example, the development of 3D printing technology allows for customized implants tailored to individual patient anatomy, which could potentially lead to better fit and function. Such innovations are likely to contribute to the market's growth, with projections indicating a CAGR of 3.54% from 2025 to 2035.

The increasing geriatric population globally is a primary driver of the Global Hip Implants Market Industry. As individuals age, the incidence of hip-related ailments, such as osteoarthritis and fractures, tends to rise significantly. For instance, by 2024, the global market is projected to reach 10.2 USD Billion, largely due to the growing number of elderly individuals requiring hip replacement surgeries. This demographic shift necessitates advanced medical solutions, thereby propelling demand for hip implants. Furthermore, the World Health Organization indicates that the population aged 65 and older is expected to double by 2050, further emphasizing the need for effective orthopedic interventions.

The growing healthcare expenditure across various regions is positively influencing the Global Hip Implants Market Industry. Governments and private sectors are investing significantly in healthcare infrastructure, which includes orthopedic services. This increase in funding allows for better access to advanced medical technologies and surgical procedures, thereby facilitating more hip replacement surgeries. For instance, countries with robust healthcare systems are witnessing a surge in hip implant procedures, reflecting the willingness to invest in quality healthcare. As healthcare spending continues to rise, the demand for hip implants is expected to grow, aligning with the overall expansion of the healthcare market.

Awareness and education initiatives regarding hip health and available treatment options are crucial drivers of the Global Hip Implants Market Industry. Healthcare organizations and professionals are increasingly focusing on educating the public about the importance of early diagnosis and treatment of hip disorders. Campaigns aimed at promoting healthy lifestyles and preventive measures are likely to lead to earlier interventions, which may require hip implants. As patients become more informed about their options, the demand for hip replacement surgeries is expected to rise. This growing awareness is essential for fostering a proactive approach to hip health, ultimately contributing to market growth.

The rising prevalence of hip disorders, including arthritis and traumatic injuries, is a significant factor driving the Global Hip Implants Market Industry. As lifestyles become more sedentary and obesity rates increase, the incidence of hip-related conditions is likely to escalate. According to health statistics, millions of individuals worldwide suffer from hip pain, leading to a greater demand for surgical interventions. This trend is expected to sustain the market's growth trajectory, with estimates suggesting that by 2035, the market could reach 14.9 USD Billion. The increasing awareness of treatment options among patients further fuels the demand for hip implants, as more individuals seek solutions for their hip-related ailments.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American hip implants market area will dominate this market. This is brought on by the increased senior population, osteoarthritis prevalence, and awareness of hip replacement procedures. In addition, the region's advanced healthcare infrastructure and attractive reimbursement policies are anticipated to fuel market revenue growth.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  HIP IMPLANTS MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe hip implants market accounts for the second-largest market share. This is due to an increase in hip replacement procedures and an aging population. More than 300,000 hip replacement surgeries are carried out annually in Europe, according to the European Hip Society, with Germany, the UK, and France doing the most operations. Additionally, rising rates of osteoarthritis and hip fractures are anticipated to fuel market revenue growth in this area. Further, the German hip implants market held the largest market share, and the UK hip implants market was the fastest growing market in the European region

The Asia-Pacific Hip implants Market is expected to grow at the fastest CAGR from 2023 to 2034. Increased knowledge of hip replacement operations and growing healthcare costs are to blame for this. Additionally, it is anticipated that an aging population and an increase in the frequency of hip fractures will fuel market revenue growth in this area. Moreover, China’s hip implants market held the largest market share, and the Indian hip implants market was the fastest growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the hip implants market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, hip implants industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  hip implants industry to benefit clients and increase the market sector. In recent years, the hip implants industry has offered some of the most significant advantages to market.

Major players in the hip implants market attempting to increase market demand by investing in research and development operations include Zimmer Biomet Holdings Inc. (US), Stryker Corporation (UK), Smith & Nephew PLC (UK), MicroPort Scientific Corporation (China), Exactech Inc. (US), OMNILife science Inc. (US), Braun Melsungen AG (Germany), DJO  Inc. (US), Aesculap Implant Systems LLC (US) and Corin (UK).

ENT, sports medicine, advanced wound treatment, orthopedic reconstruction, and trauma are among the fields in which Smith & Nephew Plc develops, produces, and markets medical devices. The company sells hip and knee implants to replace old, ill, or damaged joints, as well as robotics-assisted technologies and trauma-related products to stabilise fractures and rectify deformities. It also sells wound care goods and equipment for removing and restoring soft tissue.

Since its establishment, Corin has been a leader in orthopedic innovation and has spearheaded numerous significant advancements. Corin is delighted to have been able to use these ground-breaking solutions to enhance the quality of life for thousands of patients worldwide. The company's professional and committed teams are committed to exceeding expectations and making a positive difference in people's lives by providing superior orthopedic products and services to patients, surgeons, and healthcare providers. It has never been more crucial to offer cutting-edge conservative treatment paths with more conventional procedures due to a patient population that is growing more active and demanding.